Home

Munkavállaló Fegyvertár izom hepatic steatosis as a marker of metabolic dysfunction mozi kapcsolatba lépni Kazal

Fatty Liver | Arteriosclerosis, Thrombosis, and Vascular Biology
Fatty Liver | Arteriosclerosis, Thrombosis, and Vascular Biology

The diagnostic conundrum in non-alcoholic fatty liver disease
The diagnostic conundrum in non-alcoholic fatty liver disease

A simplified flowchart from the radiologist's perspective that... | Download Scientific Diagram
A simplified flowchart from the radiologist's perspective that... | Download Scientific Diagram

Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans - eBioMedicine
Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans - eBioMedicine

PDF) Hepatic Steatosis as a Marker of Metabolic Dysfunction
PDF) Hepatic Steatosis as a Marker of Metabolic Dysfunction

Livers | Free Full-Text | Oxidative Stress in Non-Alcoholic Fatty Liver Disease
Livers | Free Full-Text | Oxidative Stress in Non-Alcoholic Fatty Liver Disease

Role of hepatic fatty acid metabolism in the development of hepatic... | Download Scientific Diagram
Role of hepatic fatty acid metabolism in the development of hepatic... | Download Scientific Diagram

Cureus | Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease
Cureus | Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease

Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement - The Lancet Gastroenterology & Hepatology
Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement - The Lancet Gastroenterology & Hepatology

Frontiers | Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
Frontiers | Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome - The Lancet Diabetes & Endocrinology
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome - The Lancet Diabetes & Endocrinology

NAFLD as a continuum: from obesity to metabolic syndrome and diabetes | Diabetology & Metabolic Syndrome | Full Text
NAFLD as a continuum: from obesity to metabolic syndrome and diabetes | Diabetology & Metabolic Syndrome | Full Text

PDF] Hepatic Steatosis as a Marker of Metabolic Dysfunction | Semantic Scholar
PDF] Hepatic Steatosis as a Marker of Metabolic Dysfunction | Semantic Scholar

JCM | Free Full-Text | From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?
JCM | Free Full-Text | From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—New Terminology in Pediatric Patients as a Step in Good Scientific Direction?

Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications
Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications

Nutrients | Free Full-Text | Hepatic Steatosis as a Marker of Metabolic Dysfunction
Nutrients | Free Full-Text | Hepatic Steatosis as a Marker of Metabolic Dysfunction

Immune cell-mediated features of non-alcoholic steatohepatitis | Nature Reviews Immunology
Immune cell-mediated features of non-alcoholic steatohepatitis | Nature Reviews Immunology

Immunological mechanisms and therapeutic targets of fatty liver diseases | Cellular & Molecular Immunology
Immunological mechanisms and therapeutic targets of fatty liver diseases | Cellular & Molecular Immunology

Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients | Molecular Systems Biology
Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients | Molecular Systems Biology

Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity | Nature Metabolism
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity | Nature Metabolism

Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease - ScienceDirect
Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease - ScienceDirect

Frontiers | Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes
Frontiers | Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes

PDF] Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis | Semantic Scholar
PDF] Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis | Semantic Scholar

Cancers | Free Full-Text | Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to Chemoprevention
Cancers | Free Full-Text | Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to Chemoprevention

A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis - ScienceDirect
A human pluripotent stem cell model for the analysis of metabolic dysfunction in hepatic steatosis - ScienceDirect

Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment